Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Teva sandostatin lar generic approval status?Cinacalcet manufacturer coupon?Cinacalcet alternatives?Vonvendi drug market?Japan daptomycin market?
See the DrugPatentWatch profile for Kcentra
Kcentra (prothrombin complex concentrate [human]) received FDA approval on April 28, 2014. [1]
Kcentra is indicated for rapid reversal of vitamin K antagonist–associated anticoagulation (for example, warfarin) in patients with acute major bleeding and for perioperative management in certain settings requiring reversal. [1]
You can cross-check the approval date and related regulatory information in the FDA labeling and related regulatory records; DrugPatentWatch.com also tracks key regulatory/patent timeline items for Kcentra. [1] Sources [1] https://www.drugpatentwatch.com/p/kcentra
Other Questions About Kcentra :